Epidemiology, pathophysiology, and classification of the neurological symptoms of post-COVID-19 syndrome

[1]  M. Hallett,et al.  Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health Implications. , 2021, The Journal of neuropsychiatry and clinical neurosciences.

[2]  L. Kremer,et al.  A rise in cases of nitrous oxide abuse: neurological complications and biological findings , 2021, Journal of Neurology.

[3]  S. Riley,et al.  Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people , 2021, medRxiv.

[4]  I. Cobos,et al.  Dysregulation of brain and choroid plexus cell types in severe COVID-19 , 2021, Nature.

[5]  J. Hugon,et al.  Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex , 2021, Journal of Neurology.

[6]  L. Arendt-Nielsen,et al.  The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study , 2021, Cephalalgia : an international journal of headache.

[7]  M. Tremblay,et al.  Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson’s Disease , 2021, Frontiers in Cellular Neuroscience.

[8]  S. Rosenkranz,et al.  Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study , 2021, The Lancet Regional Health - Europe.

[9]  M. Landini,et al.  Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data , 2021, Frontiers in Medicine.

[10]  Michael Hittle,et al.  Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19 , 2021, The Journal of Emergency Medicine.

[11]  A. Gemignani,et al.  Long-COVID Syndrome? A Study on the Persistence of Neurological, Psychological and Physiological Symptoms , 2021, Healthcare.

[12]  F. Mattioli,et al.  Neurological and cognitive sequelae of Covid-19: a four month follow-up , 2021, Journal of Neurology.

[13]  D. Perez,et al.  Helping the Public Understand Adverse Events Associated With COVID-19 Vaccinations: Lessons Learned From Functional Neurological Disorder. , 2021, JAMA neurology.

[14]  P. Nilsson,et al.  Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. , 2021, JAMA.

[15]  M. Boldrini,et al.  How COVID-19 Affects the Brain. , 2021, JAMA psychiatry.

[16]  C. Taylor,et al.  Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers” , 2021, Annals of clinical and translational neurology.

[17]  K. Melmed,et al.  A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications , 2021, Journal of the Neurological Sciences.

[18]  E. Corruble,et al.  Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. , 2021, JAMA.

[19]  David A. Drew,et al.  Attributes and predictors of long COVID , 2021, Nature Medicine.

[20]  Milad Asgari Mehrabadi,et al.  COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler: Looking for Clarity in the Haze of the Pandemic , 2021, medRxiv.

[21]  M. Brady,et al.  Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study , 2021, BMJ Open.

[22]  Y. Benjamini,et al.  Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients , 2021, Clinical Microbiology and Infection.

[23]  A. Palmini,et al.  The COVID-19 outbreak and PNES: The impact of a ubiquitously felt stressor , 2021, Epilepsy & Behavior.

[24]  F. Bussu,et al.  Audiovestibular symptoms and sequelae in COVID-19 patients. , 2021, Journal of vestibular research : equilibrium & orientation.

[25]  D. Raoult,et al.  18F-FDG brain PET hypometabolism in patients with long COVID , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  S. Villapol,et al.  More than 50 long-term effects of COVID-19: a systematic review and meta-analysis , 2021, Scientific Reports.

[27]  K. Hoang-Xuan,et al.  The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  M. Andrés,et al.  Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study , 2021, Journal of Infection.

[29]  M. Leonardi,et al.  COVID-19 severity impacts on long-term neurological manifestation after hospitalisation , 2021, medRxiv.

[30]  D. Yapar,et al.  Quantitative evaluation and progress of olfactory dysfunction in COVID-19 , 2021, European Archives of Oto-Rhino-Laryngology.

[31]  S. Birring,et al.  Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia , 2021, ERJ Open Research.

[32]  D. García‐Azorín,et al.  Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry , 2020, Journal of the Neurological Sciences.

[33]  C. June,et al.  Cytokine Storm , 2020, The New England journal of medicine.

[34]  T. Rudroff,et al.  Post-COVID-19 Fatigue: Potential Contributing Factors , 2020, Brain sciences.

[35]  P. Weihe,et al.  Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  C. Conrad,et al.  Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 , 2020, Nature Neuroscience.

[37]  R. Sutton,et al.  Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. , 2020, Clinical medicine.

[38]  C. Gerloff,et al.  Frequent neurocognitive deficits after recovery from mild COVID-19 , 2020, Brain communications.

[39]  E. Coulthard,et al.  Teaching Neuroimages: COVID-19–Associated Acute Disseminated Encephalomyelitis With Corpus Callosal Hemorrhage , 2020, Neurology.

[40]  A. Mack,et al.  Histological Evidence for the Enteric Nervous System and the Choroid Plexus as Alternative Routes of Neuroinvasion by SARS-CoV2 , 2020, Frontiers in Neuroanatomy.

[41]  M. Aepfelbacher,et al.  Neuropathology of patients with COVID-19 in Germany: a post-mortem case series , 2020, The Lancet Neurology.

[42]  F. Bruyère,et al.  Follow-up of adults with noncritical COVID-19 two months after symptom onset , 2020, Clinical Microbiology and Infection.

[43]  M. Carmona-Abellán,et al.  Bilateral facial nerve palsy associated with COVID‐19 and Epstein–Barr virus co‐infection , 2020, European journal of neurology.

[44]  Jiao Li,et al.  Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study , 2020, Clinical Microbiology and Infection.

[45]  M. Gomez-Beldarrain,et al.  Neurological reasons for consultation and hospitalization during the COVID-19 pandemic , 2020, Neurological Sciences.

[46]  A. d’Arminio Monforte,et al.  Anxiety and depression symptoms after virological clearance of COVID‐19: A cross‐sectional study in Milan, Italy , 2020, Journal of medical virology.

[47]  B. Fantin,et al.  Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19 , 2020, Journal of Infection.

[48]  B. Millet,et al.  Covid-19-related encephalopathy: a case series with brain FDG-PET/CT findings. , 2020, European journal of neurology.

[49]  N. Maskell,et al.  Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort. , 2020, medRxiv.

[50]  F. Biglioli,et al.  Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study , 2020, The Journal of Laryngology & Otology.

[51]  Manoj Sivan,et al.  Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation , 2020, Journal of medical virology.

[52]  Eric Song,et al.  Longitudinal analyses reveal immunological misfiring in severe COVID-19 , 2020, Nature.

[53]  O. Gambini,et al.  The psychological impact of COVID-19 among a sample of Italian patients with functional neurological disorders: A preliminary study , 2020, Parkinsonism & Related Disorders.

[54]  C. Hopkins,et al.  Predominance of an altered sense of smell or taste among long-lasting symptoms in patients with mildly symptomatic COVID-19. , 2020, Rhinology.

[55]  Angelo Carfì,et al.  Persistent Symptoms in Patients After Acute COVID-19. , 2020, JAMA.

[56]  L. Politi,et al.  Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia. , 2020, JAMA neurology.

[57]  T. Segura,et al.  Neurologic manifestations in hospitalized patients with COVID-19 , 2020, Neurology.

[58]  Duzgun Yildirim,et al.  Brain MRI Findings in Patients in the Intensive Care Unit with COVID-19 Infection , 2020, Radiology.

[59]  N. Trotta,et al.  Early postmortem brain MRI findings in COVID-19 non-survivors , 2020, Neurology.

[60]  F. J. Carod-Artal.  Neurological complications of coronavirus and COVID-19. , 2020, Revista de neurologia.

[61]  Carl H. June,et al.  Cytokine release syndrome in severe COVID-19 , 2020, Science.

[62]  F. R. de Fonseca,et al.  Influencia de la infección SARS-CoV-2 sobre enfermedades neurodegenerativas y neuropsiquiátricas: ¿una pandemia demorada? , 2020, Neurología.

[63]  S. Kremer,et al.  Neurologic Features in Severe SARS-CoV-2 Infection , 2020, The New England journal of medicine.

[64]  J. Matías-Guiu,et al.  ¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2? , 2020, Neurología.

[65]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[66]  J. Benach,et al.  Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections , 2018, Annals of neurology.

[67]  Y. Ando,et al.  Autoimmune postural orthostatic tachycardia syndrome , 2018, Annals of clinical and translational neurology.

[68]  J. Farrar,et al.  Neurological complications of dengue virus infection , 2013, The Lancet Neurology.

[69]  Juan Carlos Garcia-Monco,et al.  Reversible Splenial Lesion Syndrome (RESLES): What's in a Name? , 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[70]  Arthur S Slutsky,et al.  One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. , 2007, Archives of internal medicine.

[71]  G. Navis,et al.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.

[72]  M. Dalakas.  Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing , 2020 .